F/M Emerald Life Sciences Innovation ETF (LFSC)
NASDAQ: LFSC · Real-Time Price · USD
43.40
-0.06 (-0.14%)
At close: Oct 2, 2026, 4:00 PM EDT
43.28
-0.12 (-0.28%)
After-hours: Oct 2, 2026, 7:30 PM EDT

LFSC Holdings Information

LFSC is an equity ETF with a total of 42 individual holdings. The top holdings are Corcept Therapeutics stock at 7.13%, Travere Therapeutics at 6.61%, LivaNova at 6.52%, Cogent Biosciences at 6.17%, and Spyre Therapeutics at 5.33%.

Total Holdings
42
Top 10 Percentage
52.53%
Asset Class
Equity
ETF Category
Health
Assets
120.65M
PE Ratio
n/a

Breakdown by Country

Top 25 Holdings

No.SymbolName WeightShares
1CORTCorcept Therapeutics Incorporated7.13%75,436
2TVTXTravere Therapeutics, Inc.6.61%140,245
3LIVNLivaNova PLC6.52%105,381
4COGTCogent Biosciences, Inc.6.17%235,467
5SYRESpyre Therapeutics, Inc.5.33%71,476
6BLLNBillionToOne, Inc.4.74%54,115
7REPLReplimune Group, Inc.4.55%408,338
8GHGuardant Health, Inc.4.42%30,504
9MANEVeradermics, Incorporated3.60%37,030
10AXSMAxsome Therapeutics, Inc.3.46%22,951
11MIRMMirum Pharmaceuticals, Inc.3.45%49,574
12CYTKCytokinetics, Incorporated3.41%62,691
13TMDXTransMedics Group, Inc.3.27%50,164
14TWSTTwist Bioscience Corporation2.90%18,580
15SVRASavara Inc.2.83%677,875
16UTHRUnited Therapeutics Corporation2.69%5,670
17ICUIICU Medical, Inc.2.65%20,343
18DNTHDianthus Therapeutics, Inc.2.38%32,523
19TRVITrevi Therapeutics, Inc.2.33%198,086
20VRDNViridian Therapeutics, Inc.2.18%138,752
21NKTRNektar Therapeutics2.06%52,967
22PVLAPalvella Therapeutics, Inc.1.98%17,958
23CBLLCeriBell, Inc.1.80%91,993
24CRVSCorvus Pharmaceuticals, Inc.1.56%172,119
25HNGEHinge Health, Inc.1.49%18,309
Showing 25 of 42 holdings
Subscribe to see the full list
As of Oct 1, 2026